Proton Pump Inhibitor (PPI) Pantoprazole Lyophilized Powder for Injection 40mg Antiulcer

• Customization: Available
• Application: Surgery
• Usage Mode: Intravenous Administration
• Model NO.: 40mg/10ml
• Suitable for: Adult
• State: Solid
• Shape: Powder
• Type: Biological Products
• Pharmaceutical Technology: Chemical Synthesis
• Function: Suppresses The Final Step in Gastric Acid
• Transport Package: Carton
• Specification: 40mg
• Trademark: No
• Origin: China
• HS Code: 3004909099
• Production Capacity: 5000000 Per Month

Product Description

Pantoprazole Sodium
For I.V.

It is antiacid and antiulcer drug. 

Please keep out of the reach and sight of children.
 

DOSAGE AND ADMINISTRATION

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to and during administration whenever solution and container permit.

Parenteral routes of administration other than intravenous are not recommended.

PROTONIX I.V. for Injection may be administered intravenously through a dedicated line or through a Y-site. The intravenous line should be flushed before and after administration of PROTONIX I.V. for Injection with either 5%Dextrose Injection, USP, 0.9% Sodium Chloride Injection, USP, or Lactated Ringer's Injection, USP. When administered through a Y-site, PROTONIX I.V. for Injection is compatible with the following solutions: 5% Dextrose Injection, USP, 0.9% Sodium Chloride Injection, USP, or Lactated Ringer's Injection, USP.

PROTONIX I.V. for Injection may not be compatible with products containing zinc. When PROTONIX I.V. for Injection is administered through a Y-site, immediately stop use if precipitation or discoloration occurs.


 

Pantoprazole is a PPI that suppresses the final step in gastric acid production by covalently binding to the (H+, K+)-ATPase enzyme system at the secretory surface of the gastric parietal cell. This effect leads to inhibition of both basal and stimulated gastric acid secretion irrespective of the stimulus. The binding to the (H+, K+)-ATPase results in a duration of antisecretory effect that persists longer than 24 hours for all doses tested (20 mg to 120 mg).